Since increased oxidative stress is one of the essential factors in the pathogenesis of myocardial fibrotic changes in J2N-k hamsters [17], our results suggest that HMGB1 fragment administration could become a substantial therapy for DCM. Here, HMGB1 is linked to familial dilated cardiomyopathy.